-
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 20161101
-
Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells.
PloS one 20160101
-
Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
The Journal of biological chemistry 20150626
-
FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway.
The Journal of biological chemistry 20140117
-
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Bioorganic & medicinal chemistry letters 20130801
-
Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Bioorganic & medicinal chemistry letters 20121201
-
Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20121101
-
Fibroblast growth factor receptor 3 (FGFR3) associated with the CD20 antigen regulates the rituximab-induced proliferation inhibition in B-cell lymphoma cells.
The Journal of biological chemistry 20121026
-
Transforming fusions of FGFR and TACC genes in human glioblastoma.
Science (New York, N.Y.) 20120907
-
FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 20120715
-
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.
Nature medicine 20120701
-
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
British journal of cancer 20120410
-
Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
Phytotherapy research : PTR 20120101
-
FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
Journal of bone and mineral metabolism 20120101
-
Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase.
Journal of biochemistry 20120101
-
Activation of glial FGFRs is essential in glial migration, proliferation, and survival and in glia-neuron signaling during olfactory system development.
PloS one 20120101
-
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma.
Leukemia research 20110901
-
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 20110815
-
MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
Oncogene 20110811
-
Protein kinase C delta mediates fibroblast growth factor-2-induced interferon-tau expression in bovine trophoblast.
Biology of reproduction 20110501
-
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
British journal of cancer 20110104
-
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.
Proceedings of the National Academy of Sciences of the United States of America 20101214
-
Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells.
Growth factors (Chur, Switzerland) 20100801
-
Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation.
Development (Cambridge, England) 20100315
-
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrest.
The Journal of pharmacology and experimental therapeutics 20100301
-
Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.
Journal of neuro-oncology 20090901
-
Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
Bioorganic & medicinal chemistry letters 20090701
-
Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes.
American journal of physiology. Endocrinology and metabolism 20090101
-
Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
Reproduction (Cambridge, England) 20081001
-
Fibroblast growth factor-regulated palmitoylation of the neural cell adhesion molecule determines neuronal morphogenesis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20080903
-
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
Cancer research 20080401
-
An efficient synthesis of pyrido[2,3-d]pyrimidine derivatives and related compounds under ultrasound irradiation without catalyst.
Ultrasonics sonochemistry 20080301
-
Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Clinical & experimental metastasis 20080101
-
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Proceedings of the National Academy of Sciences of the United States of America 20071218
-
Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.
Arthritis and rheumatism 20071101
-
Novel inhibitor for fibroblast growth factor receptor tyrosine kinase.
Bioorganic & medicinal chemistry letters 20070901
-
Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.
Neoplasia (New York, N.Y.) 20070201
-
Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
Molecular endocrinology (Baltimore, Md.) 20061101
-
A model for the pharmacological treatment of crouzon syndrome.
Neurosurgery 20060701
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation.
Analytical chemistry 20060201
-
Guanosine analog in the pyrido[2,3-d]pyrimidine ring system as a potential toll-like receptor agonist.
Nucleosides, nucleotides & nucleic acids 20060101
-
Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.
Journal of medicinal chemistry 20050714
-
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.
Nuclear medicine and biology 20050501
-
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
Endocrinology 20050301
-
Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 20050201
-
Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation.
The Journal of biological chemistry 20041126
-
[An alternative Abl-kinase inhibitor overcomes imatinib resistance mutations of Bcr-Abl oncogenes].
Deutsche medizinische Wochenschrift (1946) 20041001
-
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.
Leukemia 20040501
-
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins.
Oncogene 20040429
-
Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
Journal of neuroscience research 20031115
-
A one-pot microwave-assisted synthesis of pyrido[2,3-d]pyrimidines.
Molecular diversity 20030101
-
Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Acta crystallographica. Section D, Biological crystallography 20020901
-
Pyridopyrimidine analogues as novel adenosine kinase inhibitors.
Bioorganic & medicinal chemistry letters 20010820